BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 18820854)

  • 21. [The effects of amiodaron on the thyroid function].
    Kucharczyk P; Michałkiewicz D; Kucharczyk A
    Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thyroid dysfunction in long-term amiodarone administration. Correlation of the antiarrhythmic activity of amiodarone with its effect on thyroid function].
    Serdiuk SE; Bakalov SA; Golitsyn SP; Sitina VK; Molashenko NV; Platonova NM; Sviridenko NIu
    Kardiologiia; 2005; 45(1):22-7. PubMed ID: 15699935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The various effects of amiodarone on thyroid function.
    Bogazzi F; Bartalena L; Gasperi M; Braverman LE; Martino E
    Thyroid; 2001 May; 11(5):511-9. PubMed ID: 11396710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
    Gerber H; Noth D
    Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction.
    Alyan O; Arda K; Ozdemir O; Acu B; Soylu M; Demirkan D
    Med Sci Monit; 2003 Sep; 9(9):PI117-22. PubMed ID: 12960935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amiodarone treatment and thyroid disorders].
    Łacka K; Fraczek MM
    Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of amiodarone on the thyroid.
    Martino E; Bartalena L; Bogazzi F; Braverman LE
    Endocr Rev; 2001 Apr; 22(2):240-54. PubMed ID: 11294826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study.
    Stan MN; Ammash NM; Warnes CA; Brennan MD; Thapa P; Nannenga MR; Bahn RS
    Int J Cardiol; 2013 Aug; 167(3):821-6. PubMed ID: 22386642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone induced thyroid dysfunction: pathophysiology, diagnosis and management.
    Sandhu RS; Davies PH
    Adverse Drug React Toxicol Rev; 2001 Jun; 20(2):105-16. PubMed ID: 11481999
    [No Abstract]   [Full Text] [Related]  

  • 31. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy.
    Bogazzi F; Bartalena L; Dell'Unto E; Tomisti L; Rossi G; Pepe P; Tanda ML; Grasso L; Macchia E; Aghini-Lombardi F; Pinchera A; Martino E
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):533-7. PubMed ID: 17561980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical procedure in amiodarone-induced thyroid dysfunction].
    Różycka-Kosmalska M; Michalak R; Kosmalski M; Ptaszyński P; Wranicz JK; Zieleniewski W; Cygankiewicz I
    Pol Merkur Lekarski; 2016 Jan; 40(235):46-52. PubMed ID: 26891437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMIODARONE AND THYROID DYSFUNCTION.
    Medić F; Bakula M; Alfirević M; Bakula M; Mucić K; Marić N
    Acta Clin Croat; 2022 Aug; 61(2):327-341. PubMed ID: 36818930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
    Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
    Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants and outcome of amiodarone-associated thyroid dysfunction.
    Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, Clinical Course, and Risk Factors of Amiodarone-Induced Thyroid Dysfunction in Japanese Adults With Congenital Heart Disease.
    Takeuchi D; Honda K; Shinohara T; Inai K; Toyohara K; Nakanishi T
    Circ J; 2015; 79(8):1828-34. PubMed ID: 26016924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population.
    Lee KF; Lee KM; Fung TT
    Hong Kong Med J; 2010 Dec; 16(6):434-9. PubMed ID: 21135419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone-induced thyroid dysfunction in clinical practice.
    Ursella S; Testa A; Mazzone M; Gentiloni Silveri N
    Eur Rev Med Pharmacol Sci; 2006; 10(5):269-78. PubMed ID: 17121321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.